Ad
ATOS - Atossa Therapeutics Stock Trading
About | Atossa Therapeutics Inc. (NASDAQ:ATOS)
Not available
Quote | Atossa Therapeutics Inc. (NASDAQ:ATOS)
| Last: | $0.75 |
|---|---|
| Change Percent: | -2.34% |
| Open: | $0.78 |
| Close: | $0.768 |
| High: | $0.78 |
| Low: | $0.73 |
| Volume: | 62,596 |
| Last Trade Date Time: | 09/28/2023 03:00:00 am |
News | Atossa Therapeutics Inc. (NASDAQ:ATOS)
-
SEATTLE, WA / ACCESSWIRE / September 18, 2023 / One in eight women will be diagnosed with breast cancer during their lifetime. However, breast cancer does not affect all women in the same way, and individual physiology plays a huge factor. Women with dense breast tissue face a higher risk of...
-
SEATTLE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast cancer, today announces that the Company will take par...
Message Board Posts | Atossa Therapeutics Inc. (NASDAQ:ATOS)
| Subject | By | Source | When |
|---|---|---|---|
| Wow. No comments? | killrEngineer | investorshub | 06/28/2023 2:55:37 PM |
| MomentumIts trading | 4MVault | investorshub | 06/26/2023 2:08:03 PM |
| $ATOS Lets go go go go... Up up and away we go. | DrHarleyboy | investorshub | 06/26/2023 10:09:55 AM |
| $ATOS bears and bulls | DrHarleyboy | investorshub | 06/26/2023 1:31:57 AM |
| $ATOS MomentumIts gaining | willlbone | investorshub | 06/25/2023 2:39:32 AM |
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
Ad
-
SEATTLE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company developing innov...
-
SEATTLE, WA / ACCESSWIRE / September 18, 2023 / One in eight women will be diagnosed with breast cancer during their lifetime. However, breast cancer does not affect all women in the same way, and individual physiology plays a huge factor. Women with dense breast tissue face a higher risk of...
-
SEATTLE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast cancer, today announces that the Company will take par...